» Articles » PMID: 33716670

Differential Macrophage Responses in Affective Versus Non-Affective First-Episode Psychosis Patients

Overview
Specialty Cell Biology
Date 2021 Mar 15
PMID 33716670
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Increased innate immune activation and inflammation are common findings in psychotic and affective (mood) disorders such as schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD), including increased numbers and activation of monocytes and macrophages. These findings often differ depending on the disorder, for example, we previously found increases in circulating inflammatory cytokines associated with monocytes and macrophages in SCZ, while BD had increases in anti-inflammatory cytokines. Despite these differences, few studies have specifically compared immune dysfunction in affective versus non-affective psychotic disorders and none have compared functional monocyte responses across these disorders. To address this, we recruited 25 first episode psychosis (FEP) patients and 23 healthy controls (HC). FEP patients were further grouped based on the presence (AFF) or absence (NON) of mood disorder. We isolated peripheral blood mononuclear cells and cultured them for 1 week with M-CSF to obtain monocyte-derived macrophages. These cells were then stimulated for 24 h to skew them to inflammatory and alternative phenotypes, in order to identify differences in these responses. Following stimulation with LPS and LPS plus IFNγ, we found that macrophages from the NON-group had diminished inflammatory responses compared to both HC and AFF groups. Interestingly, when skewing macrophages to an alternative phenotype using LPS plus IL-4, the AFF macrophages increased production of inflammatory cytokines. Receiver operating curve analysis showed predictive power of inflammatory cytokine concentrations after LPS stimulation in the AFF group versus NON-group. Our results suggest dysfunctional monocyte responses in both affective and non-affective psychotic disorder, with varying types of immune dysfunction depending on the presence or absence of a mood component.

Citing Articles

Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?.

Chen S, Tan Y, Tian L Mol Psychiatry. 2024; 29(9):2834-2848.

PMID: 38532012 PMC: 11420084. DOI: 10.1038/s41380-024-02539-z.


Preliminary Evidence of Differentially Induced Immune Responses by Microparticle-adsorbed LPS in Patients with Crohn's Disease.

Ashwood P J Cell Immunol. 2023; 4(6):211-218.

PMID: 36865593 PMC: 9977324. DOI: 10.33696/immunology.4.152.


Emerging applications of nanotechnology in context to immunology: A comprehensive review.

Mobeen H, Safdar M, Fatima A, Afzal S, Zaman H, Mehdi Z Front Bioeng Biotechnol. 2023; 10:1024871.

PMID: 36619389 PMC: 9815620. DOI: 10.3389/fbioe.2022.1024871.


Evidence of innate immune dysfunction in first-episode psychosis patients with accompanying mood disorder.

Hughes H, Yang H, Lesh T, Carter C, Ashwood P J Neuroinflammation. 2022; 19(1):287.

PMID: 36463221 PMC: 9719666. DOI: 10.1186/s12974-022-02648-y.


Decision tree distinguish affective disorder diagnosis from psychotic disorder diagnosis with clinical and lab factors.

Liu X, Wang X, Wen C, Wan L Heliyon. 2022; 8(11):e11514.

PMID: 36406667 PMC: 9672315. DOI: 10.1016/j.heliyon.2022.e11514.


References
1.
Munkholm K, Vinberg M, Kessing L . Cytokines in bipolar disorder: a systematic review and meta-analysis. J Affect Disord. 2012; 144(1-2):16-27. DOI: 10.1016/j.jad.2012.06.010. View

2.
Goodkind M, Eickhoff S, Oathes D, Jiang Y, Chang A, Jones-Hagata L . Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry. 2015; 72(4):305-15. PMC: 4791058. DOI: 10.1001/jamapsychiatry.2014.2206. View

3.
Goldsmith D, Rapaport M, Miller B . A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016; 21(12):1696-1709. PMC: 6056174. DOI: 10.1038/mp.2016.3. View

4.
Rao J, Harry G, Rapoport S, Kim H . Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2009; 15(4):384-92. PMC: 2844920. DOI: 10.1038/mp.2009.47. View

5.
Bauer M, Teixeira A . Inflammation in psychiatric disorders: what comes first?. Ann N Y Acad Sci. 2018; 1437(1):57-67. DOI: 10.1111/nyas.13712. View